As of July 2025 REGENXBIO has a market cap of ยฃ0.31 Billion. This makes REGENXBIO the world's 7403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | ยฃ0.31 B | 8.47% |
2024 | ยฃ0.29 B | -52.8% |
2023 | ยฃ0.61 B | -23.63% |
2022 | ยฃ0.81 B | -21.67% |
2021 | ยฃ1.03 B | -16.92% |
2020 | ยฃ1.24 B | 7.9% |
2019 | ยฃ1.15 B | -3.18% |
2018 | ยฃ1.19 B | 55.79% |
2017 | ยฃ0.76 B | 92.51% |
2016 | ยฃ0.39 B | 35.04% |
2015 | ยฃ0.29 B |
On Jul 29th, 2025 the market cap of REGENXBIO was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | ยฃ0.70 B | 122.01% | ๐บ๐ธ USA |